DOI:10.2214/AJR.07.2928
AJR 2008; 190:W304-W309
© American Roentgen Ray Society
Neuroimaging of Tuberous Sclerosis: Spectrum of Pathologic Findings and Frontiers in Imaging
Babak N. Kalantari1 and
Noriko Salamon
1 Both authors: Department of Radiology, David Geffen School of Medicine at
UCLA, 10833 Le Conte Ave., Los Angeles, CA 90095-1721.
Received July 24, 2007;
accepted after revision November 13, 2007.
Certificate of merit recipient at 2007 annual meeting of the American
Roentgen Ray Society, Orlando, FL.
Address correspondence to B. Kalantari
(BKalantari{at}mednet.ucla.edu).
WEB
This is a Web exclusive article.
Abstract
OBJECTIVE. The purpose of this article is to present neuroimaging
findings in tuberous sclerosis complex, including recently developed imaging
techniques that have demonstrated clinical benefit to this patient
population.
CONCLUSION. Neuroimaging advances have improved the diagnosis of
tuberous sclerosis complex and the treatment of children with this condition.
Superimposition of functional information from PET onto MRI allows accurate
and noninvasive identification of epileptogenic tubers, improving surgical
cure rates. Magnetic source imaging can also be used to localize epileptiform
activity arising from tubers.
Keywords: FDG PET fusion imaging magnetoencephalography MRI pediatric radiology tuberous sclerosis
Introduction
Tuberous sclerosis complex (TSC) is a multisystem congenital syndrome with
widespread CNS anomalies. The clinical neurologic manifestations include
epilepsy and cognitive impairment.
Features of TSC
The intracranial features of TSC are cortical or subcortical tubers,
subependymal nodules, subependymal giant cell astrocytomas, and white matter
radial migration lines.
Tubers
Tubers are most commonly found in the cerebrum, 90% being present in the
frontal lobes [1]. On
T2-weighted and FLAIR MR images, tubers typically appear as areas of increased
signal intensity in the cortical and subcortical regions (Figs.
1A,
1B and
2A,
2B). Tubers exhibit contrast
enhancement in approximately 3–4% of cases
[2]. Ninety-five percent of
tubers are multiple, but in rare instances solitary cortical tubers are seen
[3]. Although not widely
performed, magnetization transfer T1-weighted imaging can be superior to FLAIR
imaging for detecting subtle tubers
[4]. Less commonly than in the
cerebrum, tubers are present in the cerebellum, where they may become apparent
only at histologic examination. Histologically differentiating dysmorphic
neurons in tubers from those of focal cortical dysplasia is difficult.
However, immunohistochemical evaluation with the tissue microarray method has
aided neuropathologists in making the distinction between these two entities
[5]. Unlike cortical tubers,
cerebellar tubers are usually wedge-shaped and not epileptogenic. Tubers
rarely are found in the brainstem and spinal cord. Depending on the location
of tubers, neurologic findings include abnormalities in cognition, cranial
nerve deficits, focal motor or sensory abnormalities, cerebellar dysfunction,
and gait abnormalities.

View larger version (175K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1A —4-year-old girl with tuberous sclerosis complex. Axial
T1-weighted (A) and T2-weighted (B) MR images show T1
hypointensity (arrows, A) and T2 hyperintensity
(arrows, B) in subcortical white matter of left frontal and
right parietal lobes. Gray–white matter differentiation is partially
obliterated. Findings are characteristic of cortical and subcortical
tubers.
|
|

View larger version (142K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1B —4-year-old girl with tuberous sclerosis complex. Axial
T1-weighted (A) and T2-weighted (B) MR images show T1
hypointensity (arrows, A) and T2 hyperintensity
(arrows, B) in subcortical white matter of left frontal and
right parietal lobes. Gray–white matter differentiation is partially
obliterated. Findings are characteristic of cortical and subcortical
tubers.
|
|
Subependymal Nodules
Subependymal nodules are found on the walls of the lateral ventricles and
are either discrete or roughly confluent areas of round ed hypertrophic tissue
(Fig. 3). The nodules occur
anywhere along the ventricular surface but are most commonly found at the
caudothalamic groove in the region of the foramen of Monro. Typically benign,
sub ependymal nodules can degenerate into sub ependymal giant cell astro
cytomas in 5–10% of cases. Like sub ependymal giant cell astro cytomas,
sub ependymal nodules can enhance with contrast material (Fig.
4A,
4B). Contrast enhancement, how
ever, is not necessarily an indication that a subependymal nodule is going to
grow or that surgical intervention is necessary.

View larger version (118K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4A —4-year-old girl with tuberous sclerosis complex. Axial
unenhanced T1-weighted (A) and contrast-enhanced T1-weighted (B)
MR images show enhancing subependymal nodule (black arrow) projecting
into lumen of left lateral ventricle. Subependymal nodules, which contain more
calcification, tend to become less enhanced, as in case of nodule (white
arrow) located near left atrium.
|
|

View larger version (126K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4B —4-year-old girl with tuberous sclerosis complex. Axial
unenhanced T1-weighted (A) and contrast-enhanced T1-weighted (B)
MR images show enhancing subependymal nodule (black arrow) projecting
into lumen of left lateral ventricle. Subependymal nodules, which contain more
calcification, tend to become less enhanced, as in case of nodule (white
arrow) located near left atrium.
|
|
Subependymal Giant Cell Astrocytoma
Subependymal giant cell astrocytomas can grow, often in an indolent manner,
eventually resulting in ventricular obstruction and hydro cephalus. At some
medical centers, sur geons resect subependymal giant cell astro cytomas that
exhibit interval growth on serial images. At other centers, more frequent
imaging studies are performed when a lesion becomes larger, provided no signs
or symptoms of ventricular obstruction, new neuro logic defi cit, or increased
intracranial pres sure are de tected. Lesions sometimes stabilize or stop
growing sponta neously after the size in creases. Oral rapamycin (sirolimus)
therapy has shown promise in inducing regression of sub ependymal giant cell
astrocytomas and may be an alternative to surgical resection
[6] (Fig.
5A,
5B). Rapamycin targets the mTOR
protein signaling pathway. This regulator of a number of diverse biologic
processes important for cell growth and proliferation has been found to be
hyperactive in patients with TSC.

View larger version (158K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A — 9-year-old girl with tuberous sclerosis complex and partial
complex seizures. Coronal contrast-enhanced T1-weighted image shows
homogeneously enhancing multilobulated subependymal giant cell astrocytoma
(black arrow) measuring 238 mm2 in region of left foramen
of Monro. Patient has undergone left temporal lobe resection (white
arrow).
|
|

View larger version (168K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5B — 9-year-old girl with tuberous sclerosis complex and partial
complex seizures. Coronal contrast-enhanced T1-weighted image obtained 3
months after initiation of oral rapamycin therapy shows size of subependymal
giant cell astrocytoma (black arrow) has decreased to 126
mm2. White arrow indicates site of left temporal lobe
resection.
|
|
Radial Migration Lines
Radial migration lines are believed to represent heterotopic glia and
neurons along the expected path of cortical migration
[7]. Radial migration lines are
primarily located in the subcortical white matter and are occasionally seen in
relation to tubers (Fig.
6).
Microcephaly
Patients with TSC have been found to have cerebral gray and white matter
volumes lower than those of age-matched controls
[8] (Fig.
7A,
7B). Statistically significant
microencephaly is found in both TSC patients with and those without a history
of epilepsy.

View larger version (130K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7A —6-year-old girl with tuberous sclerosis complex.
Three-dimensional MRI reconstructions show total cerebral volume of 994
cm3 (A) compared with 1,290 cm3 in age-matched
patient without tuberous sclerosis complex (B).
|
|

View larger version (133K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 7B —6-year-old girl with tuberous sclerosis complex.
Three-dimensional MRI reconstructions show total cerebral volume of 994
cm3 (A) compared with 1,290 cm3 in age-matched
patient without tuberous sclerosis complex (B).
|
|
Epilepsy in TSC
Approximately 90% of patients with TSC have seizures, and intractable
epilepsy develops in 25–30% of patients
[9]. The natural history of
epilepsy in patients with TSC typically begins in infancy and is characterized
by increasing seizure frequency and severity, poor response to antiepileptic
drugs, and diminished quality of life as the result of seizures and adverse
medication effects. The ictal onset zone is often related to a tuber and
adjoining cerebral cortex. Patients usually have multiple tubers, and
identifying the one responsible for the onset of epileptogenic activity is
difficult with video electroencephalography and conventional MRI. For children
with TSC and drug-resistant epilepsy, timely surgical resection of the
epileptogenic tuber should be considered. Tuberectomy should ideally be
performed before or during the critical time before the occurrence of
secondary epileptogenesis and multifocal epilepsy.
Diffusion Tensor MRI
Diffusion tensor imaging has two parameters: the apparent diffusion
coefficient, which is a measure of the overall magnitude of water diffusion,
and the fractional anisotropy value, which is a measure of the directionality
of diffusion motion. High apparent diffusion coefficients are observed in
tubers, and low fractional anisotropy is seen in perilesional white matter,
reflecting the presence of gliosis and hypomyelination
[10]. Statistically
significant increased apparent diffusion co efficients have been observed in
normal-appearing supratentorial white matter distant from cortical and
subcortical tubers, suggesting extensive white matter disorganization in TSC
patients compared with age-matched controls
[11]. The in formation
acquired with diffusion tensor imaging can be helpful in understanding the
propagation pattern of epileptogenesis and in predicting the degree of
cognitive impair ment in TSC patients with chronic epilepsy.
PET/MRI Fusion Imaging
Until recently, identification of the epileptogenic tuber from among many
tubers was a challenge without invasive electroencephalography or
intraoperative electrocorticography. Super imposition of functional infor
mation from 18F-FDG PET onto MR images has shown great promise for
accurate and non invasive identification of epileptogenic tubers, improving
surgical cure rates [10] (Fig.
8A,
8B). A tuber with a dis
proportionately large area of hypo metab olism compared with its size on MR
images is most likely epileptogenic (Figs.
9A,
9B,
9C and
10A,
10B).

View larger version (112K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 9B —10-month-old boy with tuberous sclerosis complex and
intractable seizures. Axial MRI/PET fusion image shows multiple areas of
hypometabolism corresponding to tubers (white arrows). Tuber (red
arrow) in right anterior temporal lobe shows disproportionately large
area of hypometabolism compared with its size in A, indicating zone is
probably epileptogenic.
|
|

View larger version (163K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 9C —10-month-old boy with tuberous sclerosis complex and
intractable seizures. Axial T2-weighted MR image shows right temporal region
after resection of epileptogenic focus (arrow). Patient became
seizure-free.
|
|

View larger version (120K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 10B —3-year-old girl with tuberous sclerosis complex and seizures.
Axial MRI/PET fusion image shows area of hypometabolism approximately equal in
size to cerebellar tuber (arrow) in keeping with fact that cerebellar
tubers are rarely epileptogenic.
|
|
Alpha-11C-Methyl-L-Tryptophan PET
The use in PET of the tryptophan analogue
-11C-methyl-L-tryptophan is another avenue for
locating epileptogenic tubers in TSC pa tients. When correlated with
intracranial electro encephalographic recordings, increased interictal
-11C-methyl-L-tryptophan uptake has been observed
in epilep togenic tubers in approximately two thirds of TSC patients
[12]. The precise mechanism
under lying the increased
-11C-methyl-L-trypto
phan uptake is not known but may be related to increased serotonin synthesis
from an epileptogenic focus
[13]. The
-11C-methyl-L-tryptophan tracer is currently not
available at most institutions, limiting its clinical application.
Magnetoencephalography/Magnetic Source Imaging
By measuring the magnetic fields produced by the electric current flowing
within neurons, spatially localized epileptiform data from magneto encephalo
graphy can be registered to anatomic image inform ation from MRI to generate
magnetic source images [14]
(Fig. 11). The magnetic source
images can be used in conjunction with PET/MRI fusion images to acquire
additional information for identification of epileptogenic tubers
[15] (Fig.
12A,
12B,
12C).

View larger version (126K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 12B —17-year-old boy with tuberous sclerosis complex and
intractable seizures. Axial PET/MRI fusion image shows multiple areas of
hypometabolism (red arrows) corresponding to tubers. Tuber in left
posterior temporal lobe shows disproportionate area hypometabolism (orange
arrow) compared with size in A, indicating zone is probably
epileptogenic.
|
|

View larger version (105K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 12C —17-year-old boy with tuberous sclerosis complex and
intractable seizures. Axial T1-weighted magnetic source image shows
epileptiform activity (yellow lines) arising from location of tuber
that exhibits hypometabolism in B.
|
|
Conclusion
Advances in neuroimaging are improving the diagnosis of TSC and the
treatment of children with this condition. Multiple-technique imaging with
MRI, PET/MRI fusion, and magnetoencephalography/magnetic source imaging plays
an important role in the noninvasive localization of epi leptogenic tubers for
possible surgical resection.
References
- Houser OW, Gomez MR. CT and MR imaging of intracranial tuberous
sclerosis. J Dermatol 1992;19
: 904–908[Medline]
- Braffman BH, Bilaniuk LT, Naidich TP, et al. MR imaging of tuberous
sclerosis: pathogenesis of this phakomatosis, use of gadopentetate
dimeglumine, and literature review. Radiology1992; 183:227
–238[Abstract/Free Full Text]
- DiPaolo D, Zimmerman RA. Solitary cortical tubers. Am J
Neuroradiol 1995; 16:1360
–1364[Abstract]
- Girard N, Zimmerman RA, Schnur RE, Haselgrove J, Christensen K.
Magnetization transfer in investigation of patients with tuberous sclerosis.
Neuroradiology 1997;39
: 523–528[CrossRef][Medline]
- Miyata H, Chiang AC, Vinters HV. Insulin signaling pathways in
cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann
Neurol 2004; 56:510
–519[CrossRef][Medline]
- Franz DN, Leonard J, Tudor C, et al. Rapamycin causes regression of
astrocytomas in tuberous sclerosis complex. Ann Neurol2006; 59:490
–498[CrossRef][Medline]
- Griffiths PD, Bolton P, Verity C. White matter abnormalities in
tuberous sclerosis complex. Acta Radiol1998; 39:482
–486[Medline]
- Chandra PS, Salamon N, Nguyen ST, et al. Infantile spasm-associated
microencephaly in tuberous sclerosis complex and cortical dysplasia.
Neurology 2007;68
: 438–445[Abstract/Free Full Text]
- Curatolo P, Bombardieri R, Verdecchia M, Seri S. Intractable
seizures in tuberous sclerosis complex: from molecular pathogenesis to
rationale for treatment. J Child Neurol2005; 20:318
–325[Abstract/Free Full Text]
- Chandra PS, Salamon N, Huang J, et al. FDG-PET/MRI coregistration
and diffusion-tensor imaging distinguish epileptogenic tubers and cortex in
patients with tuberous sclerosis complex: preliminary report.
Epilepsia 2006;47
:1543
–1549[CrossRef][Medline]
- Garaci FG, Floris R, Bozzao A, et al. Increased brain apparent
diffusion coefficient in tuberous sclerosis. Radiology2004; 232:461
–465[Abstract/Free Full Text]
- Sood S, Chugani HT. Functional neuroimaging in preoperative
evaluation of children with drug-resistant epilepsy. Childs Nerv
Syst 2006; 22:810
–820[CrossRef][Medline]
- Chugani HT, Chugani DC. Imaging of serotonin mechanisms in
epilepsy. Epilepsy Curr 2005;5
: 201–206[CrossRef][Medline]
- Makela JP, Forss N, Jaaskelainen J, Kirveskari E, Korvenoja A,
Paetau R. Magnetoencephalography in neurosurgery.
Neurosurgery 2006;59
: 493–511[CrossRef][Medline]
- Wu JY, Sutherling WW, Koh S, et al. Magnetic source imaging
localizes epileptogenic zone in children with tuberous sclerosis complex.
Neurology 2006;66
:1270
–1272[Abstract/Free Full Text]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?